Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 183

Dyndrite finds House Fund for more capital

The House Fund has made its second investment in additive manufacturing software developer Dyndrite as part of a round that raised more than $10m.

Apr 17, 2019

Boehringer Ingelheim regenerates Agomab

Boehringer Ingelheim Venture Fund has participated in a $23.8m round for the antibody developer spun out of University of Turin.

Apr 16, 2019

Extend checks in $11m series A funding

City National Bank took part as Point72 and FinTech Collective co-led the round, which increased the online credit card platform's total funding to more than $14m.

Apr 15, 2019

Pensees pins down series A funding

Computer vision and IoT technology developer Pensees has received $22.5m from investors including Foxconn and Qihoo 360.

Apr 15, 2019

Sonde sounds out corporates to raise $16m

PureTech Health and Mitsubishi Tanabe Pharma took part in the Merck Group-led series A round, which will fund work developing Sonde's voice-based medical monitoring technology.

Apr 15, 2019

Cullgen pulls in $16m

Sequoia China Capital and Highlight Capital co-led the GNI Group-backed cancer drug developer's series A round.

Apr 15, 2019

Movo hails Mutua Madrileña for series A round

The electric scooter and moped rental platform collected $22.5m in a round led by Mutua Madrileña and backed by Cabify as it prepares to expand in Latin America.

Apr 15, 2019

Corporate venturing deal net: 8-12 April 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Apr 12, 2019

Inozyme hardens up with $67m

Novo and Sanofi Ventures returned to reinvest in Yale spinout Inozyme Pharma as it looks to advance its lead mineralisation disorder drug towards the clinic.

Apr 11, 2019

Inozyme hardens up with $67m

Novo and Sanofi Ventures returned to reinvest in Inozyme Pharma as it looks to advance its lead mineralisation disorder drug towards the clinic.

Apr 11, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here